Cytosorbents - CTSO 每股淨資產
Cytosorbents正擴大在醫院部門內血液淨化系統的銷售。每股帳面價值趨勢圖顯示了這一增長，其中-0.24代表該指標的當前水平。專利保護和歐盟及美國複雜的認證程序阻擋了競爭者進入市場。同時，管理層正在擴大醫療適應症清單，並為重症治療實施過濾器。
%20-%20%E6%AF%8F%E8%82%A1%E8%B3%87%E7%94%A2%E6%B7%A8%E5%80%BC&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_CTSO_-_Cytosorbents_-_Net-Asset-Value-per-Share "CTSO CytoSorbents Corporation 每股帳面價值 (2022-07-04 - 2026-10-27) | 👁️GURU.Markets👁️")
每股帳面價值代表公司所有資產與負債之差額除以流通股數，此指標可決定投資者於公司清算時股權的實際價值。透過分析每股帳面價值，可評估Cytosorbents (CTSO) 的資本穩定性，其高利潤邊際來自定期銷售血漿淨化系統的可拋棄式過濾器。
Cytosorbents 競爭對手分析
每股淨資產 DXCM (Dexcom Corp)|PEN: 每股淨資產額|每股淨資產 NOVT|每股資產淨值 haemonetics.com|Inspire Medical Systems, Inc. (INSP) - 每股帳面價值|股票每股帳面價格 PROCEPT BioRobotics Corp|CONMED Corp. (CNMD) - 每股淨值|股票帳面價值 Pulse Medical (PLSE)|INMD: 每股淨值|picardmedical.com - 每股資產淨值|每股淨資產 Surmodics (SRDX)|SENS - 股票帳面價值|NPCE: 每股淨值|TCMD (Tactile Medical) - 每股淨值|每股淨資產 Sanuwave Health Inc SNWV|股票淨值 outsetmedical.com|Electromed, Inc. - 每股淨值|每股資產淨值 LENSAR Inc. LNSR|每股帳面價值 RCEL (AVITA Medical, Inc)|PROF - 每股淨值|每股帳面價值 Baird Medical Corp BDMD|EDAP - 股票每股帳面價格|apyxmedical.com - 每股淨值|IceCure Medical (ICCM) - 每股淨資產額|每股淨值 LUNG|每股帳面價值 TELA Bio Corp (TELA)|Sensus Healthcare, Inc. (SRTS) - 每股帳面價值|股票帳面價值 ZYXI (zynex.com)|electroCore - 每股淨資產|每股帳面價值 Vicarious Surgical Inc RBOT|IINN (Inspira Technologies Oxy B.H.N. Ltd) - 每股淨值|ICU - 每股資產淨值|每股淨值 iridex.com|Intelligent Bio Solutions Inc. (INBS) - 每股股東權益|XAIR: 每股淨值|每股淨資產額 Profusa Inc.|每股淨值 SSKN (STRATA Skin Sciences)|每股帳面價值 glucotrack.com (GCTK)|每股淨值 NAOV (NanoVibronix)|venusconcept.com - 每股淨值|NUWE - 每股淨資產|Aethlon Medical Inc (AEMD) - 每股淨資產|每股帳面價值 asensus.com ASXC|Avinger Inc (AVGR) - 股票帳面價值|每股淨值 BSGM (BioSig Technologies, Inc)|每股資產淨值 CUTR|KNW: 每股淨資產|一股帳面淨值 Inari Medical Inc NARI|每股帳面價值 NVRO (Nevro Corporation)|每股淨值 ReShape Lifesciences, Inc. RSLS|每股淨值 SILK (Silk Road Medical, Inc)